nature.com search

Loading Filters

Showing 1–24 of 24 results

Loading Filters

Editorial | 2 December 2016
The Immunology of Behavior—Exploring the Role of the Immune System in Brain Health and Illness
Neuropsychopharmacology 42 , 1–4

Rights & permissionsfor article The Immunology of Behavior—Exploring the Role of the Immune System in Brain Health and Illness . Opens in a new window.
16 July 2013
Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression
- Andrew H Miller
Neuropsychopharmacology 38 , 1607–1608

Rights & permissionsfor article Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression . Opens in a new window.
Research Highlights | 9 December 2013
Neurotherapeutic Implications of Brain-Immune Interactions
- Jennifer C Felger
- & Andrew H Miller
Neuropsychopharmacology 39 , 242–243

Rights & permissionsfor article Neurotherapeutic Implications of Brain-Immune Interactions . Opens in a new window.
Editorial | 18 September 2006
Cytokines, p38 MAP Kinase and the Pathophysiology of Depression
- Andrew H Miller
- & Charles L Raison
Neuropsychopharmacology 31 , 2089–2090

Rights & permissionsfor article Cytokines, p38 MAP Kinase and the Pathophysiology of Depression . Opens in a new window.
Research | 1 April 2020 | Open
Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls
npj Schizophrenia 6 , 1–8

Rights & permissionsfor article Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls . Opens in a new window.
Research | 10 April 2013
The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings
- Dominique Musselman
- , Erica B Royster
- , Ming Wang
- , Qi Long
- , Lisa M Trimble
- , Tara K Mann
- , Daniel S Graciaa
- , Marcia D McNutt
- , N S Freda Auyeung
- , Lindsay Oliver
- , David H Lawson
- & Andrew H Miller
Neuropsychopharmacology 38 , 1921–1928

Rights & permissionsfor article The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings . Opens in a new window.
Research | 15 January 2020
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Neuropsychopharmacology 45 , 998–1007

Rights & permissionsfor article Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression . Opens in a new window.
24 September 2002
Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis
Neuropsychopharmacology 28 , 569–576

Rights & permissionsfor article Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis . Opens in a new window.
Research | 9 November 2001
Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions
Neuropsychopharmacology 26 , 643–652

Rights & permissionsfor article Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions . Opens in a new window.
Research | 10 November 2004
Inhibition of Jun N-Terminal Kinase (JNK) Enhances Glucocorticoid Receptor-Mediated Function in Mouse Hippocampal HT22 Cells
- Xiaohong Wang
- , Huixia Wu
- , Viraj S Lakdawala
- , Fang Hu
- , Nicola D Hanson
- & Andrew H Miller
Neuropsychopharmacology 30 , 242–249

Rights & permissionsfor article Inhibition of Jun N-Terminal Kinase (JNK) Enhances Glucocorticoid Receptor-Mediated Function in Mouse Hippocampal HT22 Cells . Opens in a new window.
Research | 4 January 2006
Cognitive Dysfunction Relates to Subjective Report of Mental Fatigue in Patients with Chronic Fatigue Syndrome
Neuropsychopharmacology 31 , 1777–1784

Rights & permissionsfor article Cognitive Dysfunction Relates to Subjective Report of Mental Fatigue in Patients with Chronic Fatigue Syndrome . Opens in a new window.
Reviews | 5 December 2019
Chronic inflammation in the etiology of disease across the life span
- David Furman
- , Judith Campisi
- , Eric Verdin
- , Pedro Carrera-Bastos
- , Sasha Targ
- , Claudio Franceschi
- , Luigi Ferrucci
- , Derek W. Gilroy
- , Alessio Fasano
- , Gary W. Miller
- , Andrew H. Miller
- , Alberto Mantovani
- , Cornelia M. Weyand
- , Nir Barzilai
- , Jorg J. Goronzy
- , Thomas A. Rando
- , Rita B. Effros
- , Alejandro Lucia
- , Nicole Kleinstreuer
- & George M. Slavich
Nature Medicine 25 , 1822–1832

Rights & permissionsfor article Chronic inflammation in the etiology of disease across the life span . Opens in a new window.
Research | 30 May 2002
The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function
Neuropsychopharmacology 27 , 939–948

Rights & permissionsfor article The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function . Opens in a new window.
Research | 10 September 2018 | Open
Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia
- Ebrahim Haroon
- , Xiangchuan Chen
- , Zhihao Li
- , Thrusharth Patel
- , Bobbi J. Woolwine
- , Xiaoping P. Hu
- , Jennifer C. Felger
- & Andrew H. Miller
Translational Psychiatry 8 , 1–11

Rights & permissionsfor article Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia . Opens in a new window.
Research | 12 June 2018
What does plasma CRP tell us about peripheral and central inflammation in depression?
Molecular Psychiatry 25 , 1301–1311

Rights & permissionsfor article What does plasma CRP tell us about peripheral and central inflammation in depression? . Opens in a new window.
24 August 2016
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Neuropsychopharmacology 42 , 334–359

Rights & permissionsfor article Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation . Opens in a new window.
15 September 2016
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Neuropsychopharmacology 42 , 193–215

Rights & permissionsfor article Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders . Opens in a new window.
Reviews | 29 December 2015
The role of inflammation in depression: from evolutionary imperative to modern treatment target
- Andrew H. Miller
- & Charles L. Raison
Nature Reviews Immunology 16 , 22–34

Rights & permissionsfor article The role of inflammation in depression: from evolutionary imperative to modern treatment target . Opens in a new window.
15 September 2016
Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance
- Charles L Raison
- & Andrew H Miller
Neuropsychopharmacology 42 , 5–27

Rights & permissionsfor article Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance . Opens in a new window.
Research | 31 January 2014
IFN-Alpha-Induced Cortical and Subcortical Glutamate Changes Assessed by Magnetic Resonance Spectroscopy
- Ebrahim Haroon
- , Bobbi J Woolwine
- , Xiangchuan Chen
- , Thaddeus W Pace
- , Samir Parekh
- , James R Spivey
- , Xiaoping P Hu
- & Andrew H Miller
Neuropsychopharmacology 39 , 1777–1785

Rights & permissionsfor article IFN-Alpha-Induced Cortical and Subcortical Glutamate Changes Assessed by Magnetic Resonance Spectroscopy . Opens in a new window.
Research | 9 May 2013
Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates
- Jennifer C Felger
- , Jiyoung Mun
- , Heather L Kimmel
- , Jonathon A Nye
- , Daniel F Drake
- , Carla R Hernandez
- , Amanda A Freeman
- , David B Rye
- , Mark M Goodman
- , Leonard L Howell
- & Andrew H Miller
Neuropsychopharmacology 38 , 2179–2187

Rights & permissionsfor article Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates . Opens in a new window.
Research | 22 February 2012
Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine
Neuropsychopharmacology 37 , 1444–1454

Rights & permissionsfor article Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine . Opens in a new window.
Research | 28 February 2007
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Neuropsychopharmacology 32 , 2384–2392

Rights & permissionsfor article Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy . Opens in a new window.
14 September 2011
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
Neuropsychopharmacology 37 , 137–162

Rights & permissionsfor article Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior . Opens in a new window.

Refine your results by…

Filters

Filter By:

The Immunology of Behavior—Exploring the Role of the Immune System in Brain Health and Illness

Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression

Neurotherapeutic Implications of Brain-Immune Interactions

Cytokines, p38 MAP Kinase and the Pathophysiology of Depression

Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls

The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings

Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression

Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis

Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions

Inhibition of Jun N-Terminal Kinase (JNK) Enhances Glucocorticoid Receptor-Mediated Function in Mouse Hippocampal HT22 Cells

Cognitive Dysfunction Relates to Subjective Report of Mental Fatigue in Patients with Chronic Fatigue Syndrome

Chronic inflammation in the etiology of disease across the life span

The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function

Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia

What does plasma CRP tell us about peripheral and central inflammation in depression?

Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance

IFN-Alpha-Induced Cortical and Subcortical Glutamate Changes Assessed by Magnetic Resonance Spectroscopy

Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates

Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine

Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy

Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters